Robertsonian Translocations: Hidden Causes of Miscarriage

Detection of Germline Mosaicism for Robertsonian Translocation 14;14: A Case Report. Viñals Gonzalez X, Mora F, Arshad F, Zhang Y, Babariya D, Wells D, Tozer A. J Reprod Infertil 2024;25(1):66–71.

Case reportOne couple4 embryos testedJ Reprod Infertil, 2024Open access
Case report

This describes one couple, with no comparison group, so it can’t show how common this is. The conclusion is the authors’ inference: the translocation was not seen in the patient’s blood tests, and the paper reports no direct testing of her eggs.

Normal blood tests, but a pattern in the embryos

A 33-year-old woman sought fertility treatment after six miscarriages. Chromosome checks on her blood and her husband’s blood looked normal. Yet when her embryos were tested, the same chromosome, chromosome 14, kept turning up with missing or extra copies.

The authors’ best explanation is a hidden rearrangement called a Robertsonian translocation, affecting some or all of her eggs but not visible in her blood. This is their interpretation of the results, not something the tests showed directly.

What is a Robertsonian translocation?

All our genetic information is contained in chromosomes. Normally, you have 46 chromosomes arranged in 23 pairs. In a Robertsonian translocation, two chromosomes fuse together. This can cause confusion within the cell, leading to missing or extra chromosomes in embryos. In this case the two copies of chromosome 14 were fused to each other, which the paper describes as extremely rare.

Blood looks normal. Chromosome checks on both partners’ blood were normal on two occasions.

Embryos tell a different story. All four embryos tested had a chromosome 14 error: two were missing a copy and two had an extra copy.

The clue points to the egg. All four errors traced back to the egg, and sperm testing did not show a raised rate.

Regular blood tests only check the genetic makeup of certain cells, but can’t check for specific sub-types (ie, eggs).

6miscarriages, most at 4–5 weeks of pregnancy
0 of 2embryo transfers led to a pregnancy (a fresh and a frozen transfer both tested negative)
4 of 4embryos tested had a chromosome 14 error, and all four traced to the egg

Each circle is one embryo tested. All four had a chromosome 14 error.

“If you’re facing repeated failures in IVF, the answer might be in the fine print of your DNA.”Dr Viñals Gonzalez, quoted in our earlier post

What this does and doesn’t mean

A hidden cause is plausible

The authors believe the pattern of results best fits a chromosome 14 rearrangement in some or all of her eggs, explaining the repeated losses and embryo errors.

Not his sperm

Sperm testing found no raised rate of chromosome 14 errors, and all four embryo errors came from the egg side.

One couple, not a rule

This is a single case. It can’t tell us how often this happens or whether it explains other people’s miscarriages.

Open questions remain

It isn’t known whether all of her eggs carry the rearrangement or whether some are normal. Only four embryos were tested, so normal eggs can’t be ruled out.

Practical takeaways

Karyotype

If you’ve had multiple miscarriages, ask about genetic testing options. A karyotype (blood test) is usually the starting point. Here it was normal, and testing the embryos gave the further clue.

Use support resources

Seek emotional support and explore genetic counselling to supplement clinic information. Genetic findings can be overwhelming but empower informed decisions.

Ask how results fit together

The authors suggest that combining results from different genetic tests can help couples set realistic expectations.

Talk through all your options

The authors say a finding like this may prompt couples to consider a wider range of options, including donor eggs or embryo adoption.

How the evidence was gathered

All figures below are raw counts or percentages from one couple. Nothing is adjusted.

Miscarriage work-up. Six miscarriages. Karyotype of the last product of conception: der(14;14)(q10;q10). Parental blood karyotypes normal on two occasions. The laboratory judged the rearrangement most likely de novo, with a low recurrence risk.

IVF and PGT-A. First clinic: 7 mature oocytes, 5 fertilised; a fresh and a frozen single embryo transfer both gave negative urine pregnancy tests. Second cycle (April 2023): PGTseq (targeted amplification) on trophectoderm biopsies of about 5 cells.

Origin tests. Sperm FISH on the husband (6,175 sperm analysed). Genotyping of about 5,000 SNPs across the genome, compared in embryos and parental blood, to trace the origin of chromosome 14 errors.

Second IVF cycle: embryo funnel

Counts, not percentages. The 4 biopsied embryos were the 3 blastocysts from the fresh cycle plus 1 cryopreserved embryo from the earlier cycle.

Oocytes obtained
5
Fertilised
5
Reached blastocyst stage
3
Biopsied (3 fresh + 1 frozen)
4
Chromosome 14 abnormality
4
Maternal (oocyte) origin
4

PGT-A results

FindingEmbryos (n = 4)Origin of chromosome 14 error
Monosomy 142Maternal
Trisomy 141Maternal
Trisomy 14 with mosaic loss of chromosome 151Maternal (chromosome 14 error)Origin of the chromosome 15 change is not stated

Sperm aneuploidy test

0.10%disomy for chromosome 14 in the husband’s sperm
0.13%in the internal control group of 44 fertile men with normal sperm parameters

Raw percentages of sperm, from 6,175 sperm analysed. The result was normal for chromosomes 13, 14, 18, 21 and the sex chromosomes, meaning no elevated risk of sperm chromosomal abnormalities. The paper names a chi-square or Fisher exact test but gives no test statistic or p-value. Semen analysis (2023) was also normal: count 102 M/ml, 71% progressive, 7% normal forms; sperm DNA fragmentation index 9.4% (2020).

The wife’s AMH was below the reference range (4.1–58 pmol/L) in both 2021 and 2022. The exact values are not quoted here because the paper’s text and Figure 1 differ.

Effect sizes and confidence intervals

None reported

This is a single case report. It gives no effect sizes, confidence intervals or significance tests for its main findings, so none are shown.

How the authors built the inference

The authors list four observations behind their conclusion of a maternal 14;14 translocation affecting some or all oocytes. Two points remain inferred or unknown.

1
Six miscarriages, one with a der(14;14)(q10;q10) product of conception
Supports
2
Unusually high incidence of chromosome 14 abnormalities in embryos (4 of 4 tested)
Supports
3
SNP analysis: all four chromosome 14 abnormalities were of maternal origin
Supports
4
Sperm FISH: no elevated frequency of chromosome 14 abnormalities
Supports
?
Translocation not detected in blood from either parent, so the authors infer mosaicism limited to a subpopulation of her cells
Inferred
?
Whether any of her oocytes have a normal karyotype
Unknown

The authors’ explanation

The authors propose that the patient is mosaic, with the translocation restricted to a subpopulation of her cells and so missed on blood karyotyping. They state that oocytes carrying a 14;14 translocation have a significantly low probability of developing into a viable embryo. They consider that abnormalities linked to the translocation are probably present in most of her oocytes, but note that the small number of embryos tested means oocytes with a normal karyotype cannot be excluded. In their introduction they note that aneuploidies arising from mitotic errors in oogonia may not show on somatic karyotypes, which could lead to underestimates of germline mosaicism. None of this was tested directly in this case.

Context from earlier work

Cited background from the paper’s introduction, not findings of this case.

1.2–4.4%reported incidence of structural chromosome alterations in first-trimester miscarriages
~1 in 1,000approximate incidence of Robertsonian translocation in individuals
1 in 100couples with recurrent pregnancy loss estimated to be carriers

Robertsonian translocations between homologous chromosomes are described as extremely rare. Carriers tend to be infertile and to have recurrent miscarriage, because nearly 100% of their gametes are expected to be nullisomic or disomic for the translocated chromosome. A normal embryo would arise only through uniparental disomy, itself extremely rare and linked to abnormal expression of imprinted genes.

The authors also discuss Cinar et al. (2011), who reported a 56-year-old man with a 45,XY,t(14;14)(q10;q10) karyotype. Sperm FISH found 13% of his sperm cells normal for chromosome 14. He had two healthy children from a previous relationship, which the authors take to exclude uniparental disomy as the explanation. They describe it as showing the intricacy of predicted germline mosaicism.

What the authors recommend

Advanced testing and personalised treatment

Germline mosaicism highlights the need for advanced testing and personalised treatments. Integrating data from several genetic analyses could improve how treatment expectations are managed.

Emotional support and counselling

The authors stress the emotional strain, grief and loss of recurrent miscarriage. They recommend coping resources and a comprehensive, holistic approach to genetic counselling.

A broader range of options

Even though PGT-A was performed, the mosaic nature of the translocation may prompt consideration of donor eggs or embryo adoption.

Caveats the authors state: a single case; the translocation was not detected in parental blood, so maternal mosaicism is inferred (“seems likely”); it is uncertain whether all of the patient’s oocytes carry it; only a limited number of embryos was tested, so oocytes with a normal karyotype cannot be excluded. Source: Viñals Gonzalez et al., J Reprod Infertil 2024;25(1):66–71, doi:10.18502/jri.v25i1.15202. Casa Origen summarises research for information only; this is not medical advice.

Previous
Previous

Can NMN Boost Egg Quality?

Next
Next

When Time Isn’t Neutral: Paternal Age Over 50 and Fertility